Progress in Defining the Role of RSV in Allergy and Asthma: From Clinical Observations to Animal Models by Kalina, W. V. & Gershwin, L. J.
Progress in Deﬁning the Role of RSV in Allergy and Asthma:
From Clinical Observations to Animal Models
W.V. KALINA and L.J. GERSHWIN*
Department of Pathology, Microbiology, and Immunology, School of Veterinary Medicine, University of California, Davis, CA 95616, USA
Respiratory syncytial virus (RSV), an RNA virus in the family Paramyxoviridae, causes respiratory
disease in humans. A closely related bovine RSV is responsible for a remarkably similar disease
syndrome in young cattle. Severe RSV disease is characterized by bronchiolitis. The impact of RSVon
human health is demonstrated annually when infants are admitted to the hospital in large numbers.
Nearly every child will have been infected with RSV by the age of 3 years. While the disease is most
severe in young infants and elderly people, it can re-infect adults causing mild upper respiratory tract
disease throughout life. In addition, there is growing evidence that RSV infection may also predispose
some children to the development of asthma. This is based on the observation that children whowheeze
with RSV-induced bronchiolitis are more likely to develop into allergic asthmatics. Recent studies
describe attempts to create an RSVinduced asthma model in mice and other species; these have shown
some degree of success. Such reports of case studies and animal models have suggested a wide range of
factors possibly contributing to RSV induced asthma, these include timing of RSV infection with
respect to allergen exposure, prior allergic sensitization, environmental conditions, exposure to
endotoxin, and the genetic background of the person or animal. Herein, we primarily focus on the
inﬂuence of RSVinfection and inhalation of extraneous substances (such as allergens or endotoxin) on
development of allergic asthma.
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INTRODUCTION
Clinical observations that children who are infected
with RSV and acquire bronchiolitis at an early age are
more likely to develop childhood asthma are numerous
(Sigurs et al., 1995, 2000; Juntti et al., 2003).
Moreover, other reports have shown that allergens
and environmental pollutant exposure can alter the
outcome of RSV infection (Gurkan et al., 2000; Makela
et al., 2003). In murine models, researchers have
demonstrated increased airway hyperresponsiveness
when allergen is administered before infection to
achieve sensitization and then challenge exposure is
performed during infection (Peebles et al., 2001). This
phenomenon has been demonstrated not only in the
mouse but also in bovine models of RSV infection.
A variety of different extraneous antigens have been
employed to demonstrate this effect. These antigens
include: cockroach allergen, ragweed, carbon black,
Micropolyspora faeni (currently known as Saccharo-
polyspora rectivirgula), ovalbumin (OVA), and
Dermatophagoides farinae (Df) (Leibovitz et al.,
1988; Gershwin and Giri, 1990, 1992, Gershwin et al.,
1994; Lukacs et al., 2001; Peebles et al., 2001; Foster
et al., 2003; Lambert et al., 2003).
Unique aspects of RSV pathogenesis are important for
understanding how RSV inﬂuences asthma pathogenesis,
and how pathogenesis of RSV infection is inﬂuenced by
inhalation of allergens. Thus, herein we discuss early and
late immune responses to RSVand the interaction between
inhaled allergens and RSV infection.
RSV-cellular Attachment: A possible Instigator of
Allergy
Unlike many other viruses, RSV’s mechanism for entry
into susceptible cells has not fully been elucidated. In a
recent review, RSV was said to bind toll-like receptor 4
(TLR-4) prior to cell entry. TLR-4, CX3R1 (fractalkine
receptor), sodium heparin and caveolin have been
suggested as potential cellular receptors that are important
for viral entry (Werling et al., 1999; Karger et al., 2001;
Harris and Werling, 2003). TLR-4 binding to RSV does
occur but is apparently not required to establish an
infection. Kurt-Jones et al. demonstrated that RSV viral
titers in the lungs of TLR-4 deﬁcient C57BL10/ScCr mice
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found that CD14 is necessary in conjunction with TLR-4
for stimulation of IL-6, TNFa, IL-8 and IL-1b production
(Kurt-Jones et al., 2000). The results of this study infer
that the initial immune response to RSV may be instigated
by TLR-4 binding to RSV.
TLR-4 expression is not normally seen in airway
epithelial cells unless they are exposed to high amounts of
LPS. Monick et al. evaluated the ability of A549 cells to
produce IL-8 after exposure to LPS. They found that
A549 cells produce very little IL-8 in response to LPS,
which was due to low expression of TLR-4 (Monick et al.,
2003). They also showed that infection with live RSV
induces A549 cells to increase both the expression of
TLR-4 and the response to LPS. Under these conditions,
RSV may prime airway epithelial cells to secrete pro-
inﬂammatory mediators in response to RSV or bacteria.
LPS has also been shown to cause mast cell secretion
of IL-5, IL-10 and IL-13 but not TNFa via TLR-4
(Varadaradjalou et al., 2003). Whether or not RSV
induces mast cell activation by interaction with TLR-4
has not been elucidated. Nevertheless, RSV induced TLR-
4 expression may hypersensitize epithelial cells to LPS
and thereby instigate potent inﬂammatory responses.
This is feasible because cross-linking of TLR-4, by RSV
or LPS, also has an innate effect in increasing cellular
expression of TLR-4. Increased TLR-4 expression on
primary lung epithelial cells, caused by RSV, increases
their ability to respond to lower amounts of bacterial or
other LPS sources. This dual RSV and LPS exposure
causes epithelial cells to secrete greater TNFa and/or IL-8
than either one alone (Monick et al., 2003).
The contention that RSV primes airway epithelial cells
to express TLR-4 has caused speculation that RSV
infected epithelial cells are hypersensitive to LPS. This is
ofimportance in cases of RSVinduced asthma, where LPS
administration almost always induces acute attacks in
children (George et al., 2001; Park et al., 2001). It has
been proposed that LPS contaminated grain dust, house
dust and air pollution particles may act an adjuvants for
responses to these allergens (Monick et al., 2003).
The LPS in these systems may instigate allergic
sensitization, in airways, by mediating the production of
IL-1 and enhance expression of co-stimulatory markers on
antigen presenting cells. This mixture of cytokines and
chemokines may attract lymphocytes to the lung and also,
with increased expression of CD80/86 on monocytes,
macrophages and epithelial cells, may enhance immune
responses to allergens.
Cell Types Involved in Early RSV Infection: Roles of
Early Mediators in Th2 Responses
As mentioned above, monocytes, after interaction with
RSV, express co-stimulatory molecules CD80/86 and
present RSV peptides on MHCI and II (Soukup and
Becker, 2003). Eosinophils also are active in RSV
infections. They have been shown to present rhinoviral
antigens to T cells and inactivate RSV by release of
eosinophilic cationic protein (ECP) (Handzel et al., 1998;
Soukup and Becker, 2003). Exposure to the virus,
promotes epithelial cells to release GM-CSF, G-CSF and
RANTES, which attract more eosinophils and monocytes
to the infection site. Furthermore, monocyte’s release
IL-16 when exposed to RSV, which attracts CD4þ T cells
to the lung. Macrophages along with epithelial cells can
secrete PGE2, IL-10 and IL-11 (Bartz et al., 2002). These
anti-inﬂammatory and Th1 blocking cytokines may
always be produced in RSV infection as a negative
feedback to the pro-inﬂammatory response. Allergen
exposure, however, may enhance expression of the Th2
cytokines.
NK cells are the ﬁrst lymphocyte sub-population to
enter the lung during an RSVinfection. By day 4, NK cells
are the dominant lung lymphocyte population. They are
responsible for the high amounts of IFNg production seen
early in RSV infections (Hussell and Openshaw, 1998).
IL-10, in addition to being immunosuppressive to Th1
responses, is produced early in RSV infections and has an
anti-viral effect by increasing the expression of FasL on
macrophages and cytotoxic T cells (Ruan et al., 2001).
Therefore, viral clearance is possible under Th2
conditions, however, immunological memory may be
less protective. IL-10 is also necessary for sustaining
mucosal tolerance by exerting its effects on alveolar
macrophages and dendritic cells, however, in the presence
of TLR-4 binding RSV, IL-10 may not offer enough
suppression to prevent a TLR-4 mediated inﬂammatory
response (Akbari et al., 2001; Macaubas et al., 2003).
Secondary exposure to, or challenge with allergens under
these conditions could likely lead to the rapid recruitment
and proliferation of allergen speciﬁc Th2 memory cells
whose cytokine mileu would indirectly affect responses
to RSV.
The Role of Mediators Induced during Late RSV
Infection on Development of Th2 Responses to
Allergens
IL-4, IL-5, IL-13 and IFNg are usually produced in the
lung several days after initiation of an RSV infection.
Lung IL-10 and IFNg gene expression plateau around day
3 and remain elevated until day 7 in a cotton rat model of
RSV infection (Blanco et al., 2002). IL-4 message, in
lymph derived lymphocytes, has been detected from days
1 to 10, post infection in a bovine model of RSV infection;
peripheral blood IL-13 appears on day 8 and remains
elevated beyond day 12 in a BALB/c mouse RSV model
(Gershwin et al., 2000; Lukacs et al., 2001). High levels of
IL-5 have been noted, by ELISA, in bronchio-alveolar
lavage ﬂuid on day 7 in RSV infected BALB/c mice
(Schwarze et al., 1999a,b). These cytokines have been
associated with enhanced or delayed clearance, depending
on which cytokine is predominately expressed. In
conjunction with allergen sensitization, IL-4, IL-5, IL-13
have been shown to be important in promoting airway
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2003). IL-10 is critical in mediating airway hyperrespon-
siveness in RSV infections without allergen. It has been
shown that RSV infected IL-10 deﬁcient mice produce
less airway hyperresponsiveness, measured by lung
resistance to increasing concentrations of methacholine,
than wild type mice (Makela et al., 2002). In general, RSV
infection can induce expression of IL-4, IL-13, IL-5, IL-
10, IL-12, IFNg and others, but their relative proportions
to one another can be inﬂuenced by allergens, pollution or
dust in the environment (Gershwin et al., 2000; Bartz
et al., 2002).
IL-4, IL-5, IL-10, IL-11 and IL-13 have been groupedin
the Th2 class of cytokines that are most commonly
associated with airway hyperresponsiveness in RSV
infections. These cytokines contribute towards immune
response modulation. IL-4 and IL-13, for instance, can
promote B cell proliferation and IgE production, and IL-4
has been shown to inhibit nitric oxide (NO) production in
A549 cells (Kao et al., 2001). NO is important in
regulating the IL-12/IL-10 balance secreted by alveolar
macrophages. Overproduction of IL-4 can lead to large
amounts of IL-10, which may help to promote IgE
production. IL-10 induced anergy is commonly observed
in cases where allergen is repeatedly administered,
however, during viral infections, IL-4 and IFNg increase
expression of MHCII on alveolar macrophages. This
increase in MHCII and antigen presentation may instigate
immune responses to allergens in the lung (Jutel et al.,
2003; Macaubas et al., 2003; Maurer et al., 2003). IL-11
has also been implicated in airway hyperresponsiveness in
RSV infections and may augment IL-4 and other Th2
responses to allergens (Einarsson et al., 1996).
Th1 cytokines such as IFNg,p r o d u c e di nR S V
infection, participate in both viral clearance and pathology
(Ostler et al., 2002). In a study by Ostler et al. cytotoxic T
cells, which require IFNg for proliferation and activation,
were thought to contribute to lung pathology. In vivo
generated RSV M2 p85-90 speciﬁc CTL effectors that
were adoptively transferred to RSV infected BALB/c
mice promoted viral clearance with extensive peri-
bronchiolar and intra-alveolar inﬁltrates (Ostler et al.,
2002). This pathological condition was observed clinically
as reduced activity, loss of fur, hunch posture and weight
loss. It has been proposed that CTLs do not immediately
lyse virus infected cells. Instead, the target cell is signaled
to secret pro-inﬂammatory mediators such as monocyte
chemoattractant protein-1 (MCP-1) (Small et al., 2001).
Mucosal homing lymphocytes (CD54þ and CD102þ)
express IFNg more often than IL-4 and may account for
predominate Th1 responses reported in RSV infections
(Tripp et al., 2000). However, in a study by Spender et al.,
BALB/c mice immunized with vaccinia virus expressing
RSV G protein produced high amounts of BAL cell
derived IL-5 mRNA, a Th2 cytokine, despite high IFNg
mRNA levels. The authors stated that increases in Th2
cytokines and lung eosinophilia can persist regardless
of IFNg producing Th1 cells (Spender et al., 1998).
Some researchers have proposed separate roles for two
types of cytotoxic T cells that contribute to allergen
induced airway hyperresponsiveness in RSV infections.
One type is a CD8þ subset of short-lived anti-viral/IFNg
producing T cells and the other is a long-lived CD8þ/IL-5
producing subset (Schwarze et al., 1999a,b). The latter
subset may recruit eosinophils to the lung long after
resolution of an RSV infection. Whether or not both
subsets of CTLs regulate each other’s expression of
cytokines is not know.
Mechanisms of Allergen Induced
RSV Immunomodulation
Researchers investigating the interaction of RSV with
allergen are divided into two main groups: (1) those that
are interested in how allergic sensitization and challenge
can affect the outcome and severity (exacerbation) of RSV
bronchiolitis and (2) those interested in the development
of asthma subsequent to RSV infections. In the ﬁrst case,
investigators sensitize animals with allergen and challenge
during RSV infection, and the second employs RSV
infection followed by allergen aerosol. Both models
induce airway hyperresponsiveness to varying degrees.
Some have shown that RSV bronchiolitis is more severe in
the ﬁrst case. In several experimental systems, allergen
sensitization preceded infection by several weeks and then
challenge took place during RSV infection (Gershwin
et al., 1990; Gershwin and Giri, 1992; Barends et al.,
2002; Lambert et al., 2003). These experimental systems
employed allergens such as Micropolyspora faeni
(currently known as Saccharopolyspora rectivirgula),
Ovalbumin (OVA), or carbon black. To study RSV
exacerbation, allergen sensitization must occur long
before infection is to take place. This is needed to
establish a Th2, IgE producing immune response to the
allergen, which takes at least 2 weeks. After that time, IgE
produced by lymph node or mucosal plasma cells will
have sensitized tissue mast cells. When allergen challenge
takes place the resulting activation of mast cells and
release of mast cell byproducts (histamine, leukotrienes
B4, C4, D4, E4, prostaglandins D2 and E2 and TNFa)
cause a massive inﬂammatory tissue response and
recruitment of granulocytes and lymphocytes. This
reaction is characteristic of type I hypersensitivity.
If this occurs during infection, the additive impact of
chemokine production and resultant inﬂammation wor-
sens disease. This has been documented in a bovine RSV
model (Gershwin and Giri, 1992). RSV infection has also
been shown to stimulate leukotriene release in nasal
secretions of infants suffering from acute bronchiolitis
(Volovitz et al., 1988).
Th2 cytokines produced during allergen challenge, in
conjunction with the previously mentioned pro-inﬂam-
matory mediators, can lead to dominating RSV Th2
responses. Allergen challenge during RSV infection has
been shown to increase IL-5, IL-10, IL-13 and lung
eosinophils. Although IL-10 expression is increased in
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not seem to enhance airway hyperresponsiveness. This
was demonstrated by Makela et al. using C57BL IL-10
knockout mice. They showed that there was no difference
in airway hyperresponsiveness between IL-10 knockout
mice and normal mice, and that elevated IL-5 and lung
eosinophils, which were not induced by IL-10, were
involved in airway hyperresponsiveness (Makela et al.,
2002). In the case of IL-13, the indirect manifestations of
its release are increased expression of MCP-3, which
triggers histamine release in mast cells, attraction of
eosinophils and basophils, and increased monocyte
derived chemokine (MDC) (Lukacs et al., 2001). Release
of these mediators can be initiated by PGD2, which is
produced in allergic reactions. Honda et al. demonstrated
that aerosolization with PGD2 1 day prior to
allergen challenge enhances production of MDC, a
chemoattractant in Th2 cells, as well as, IL-4 and IL-5
expression (Honda et al., 2003). In addition, activated
mast cells, as previously mentioned, secrete numerous
Th2 cytokines. They concluded that PGD2 accelerates
Th2 type inﬂammation by inducing MDC. Since RSV
enhances PGD2 production, the combination of an
allergic response and virus infection would be expected
to enhance disease.
Mechanisms of RSV Induced Allergen
Immunomodulation
Allergen exposure prior to RSV infection worsens disease
in animal models and is likely to play a role in human
infections. However, children whom acquire a severe RSV
infection at a very young age have a greater likelihood of
developing asthma or allergic disease. In two cohort
studies, children with severe RSV infections were more
likely to produce IgE to common allergens after an
infection. Sigurs et al. found that children, averaging 31
2
months old, whom develop severe RSV bronchiolitis have
a greater likelihood of developing childhood asthma
(Sigurs et al., 1995). Children who developed RSV, early
in life, were more likely to produce IgE to common food
and inhalant allergens such as egg white, cat, birch and
mite (Sigurs et al., 1995). A cohort study done by Foster
et al. also found that IgE, to common allergens, was more
common after severe RSV infections in young children
(Foster et al., 1996). Furthermore, RSV infection after 2
years of age did not play a role in sensitization against
aeroallergens (Foster et al., 1996). This implies that RSV
plays a pivotal role in inﬂuencing immune responses to
allergens in young children.
Animal models have been used to investigate the role of
RSV infection and subsequent allergic sensitization.
In experiments, when RSV is administered prior to
allergen aerosol, there is no immediate effect on clinical
signs. RSV speciﬁc IgG and Th cell proﬁle does not
appear to be altered, however, some investigators have
reported an increase in allergen speciﬁc IgG (Freihorst
et al., 1988; Gershwin et al., 1994; Dakhama et al., 1999).
Dakhama et al. showed that guinea pigs infected with
RSV and then aerosolized with OVA developed higher
titers of OVA speciﬁc IgG1. Freihorst et al. demonstrated
higher IgG in RSV infected OVA aerosolized BALB/c
mice; Gershwin et al. reported a similar ﬁnding in BRSV
infected calves subsequently aerosolized with Micropoly-
spora faeni (currently known as Saccharopolyspora
rectivirgula). Whereas, others, using different OVA
aerosol schedules (starting day 10 post infection) in
BALB/c mice, have not noted an increase in allergen
speciﬁc IgG but have observed increases in airway
hyperresponsiveness (Schwarze et al., 1997). O’Donnell
et al. showed that aerosol of OVA during acute RSV
infection (days 4–13) produced anaphylactic shock in all
BALB/c mice when challenged with intradermal OVA 5
days after the last aerosol (O’Donnell and Openshaw,
1998). They also noted that the timing of aerosols
inﬂuenced anaphylaxis and OVA speciﬁc IgG1 levels.
Mice that were given OVA aerosols from days 11–20 and
18–27 post infection failed to undergo anaphylaxis on
days 25 and 32, respectively when challenged intra-
dermally with OVA. In addition, IgG1 levels were not
affected. Intracellular production of IL-4 was enhanced by
virus infection during exposure in this model.
IL-4 and IL-13 have been implicated in airway
hyperresponsiveness (Schwarze et al., 1997). Barends
et al. noted that if allergen challenge takes place during an
RSV infection, then IL-4 and IL-5 responses to the
allergen become enhanced (Barends et al., 2002).
In addition, if IFNgR (Receptor) knockout mice are
OVA sensitized and challenged during RSV infection, a
strong IL-4/IL-13 response develops with increasing
numbers of pulmonary eosinophils (Barends et al., 2002).
The levels of IL-4/IL-13 and pulmonary eosinophils are
decreased signiﬁcantly in OVA/RSV mice with functional
IFNgR. Although airway hyperresponsiveness occurs in
both models, the effect of allergen challenge is less in the
mice that have functional IFNgR. In another study using
mice, Lambert et al. showed that carbon black exposure
prior to infection also results in higher Th2 cytokine IL-13
protein levels in BAL on days 4, 7 and 10. Decreases in
IP-10, TNFa and IFNg in carbon black/RSV infected
mice were lower than RSV infected controls (Lambert
et al., 2003). These cytokines are important for the
generation of Th1 and anti-viral responses and their
suppression early in infection, as shown by Lambert et al.,
may promote allergic responses in the lung.
In contrast, Peebles et al. found that mice immunized
i.p. with OVA in alum and subsequently aerosolized with
OVA on days 22 through 6 post RSV infection found no
increase in lung IL-4, IL-5 or IL-13 mRNA expression
despite greater airwayhyperresponsiveness(Peebles etal.,
2001). There is an explanation for both results. Since two
immune responses are taking place at once, and the RSV
speciﬁc response has preceded the allergic response, the
outcome of allergic disease may depend on the RSV
immune phenotype. This could be inﬂuenced by any one
or more of the following factors: prior allergen exposure,
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of mice in experimental models, prior history of microbial
infections (hygiene hypothesis).
Whereas some investigators have argued that RSV
infection immunomodulates allergenic responses to a Th1
phenotype, others have advocated Th2 or Th0 response
augmentation. Leibovitz et al. aerosolized mice with
ragweed allergen following RSV infection and measured
higher amounts of both ragweed speciﬁc IgE and IgG in
mice than non-infected controls (Leibovitz et al., 1988).
Noma et al. demonstrated that allergic responses are
inﬂuenced by IL-2 produced in RSV infections, which can
amplify allergen Th2 responses (Noma et al., 1996). This,
once again, points to the Th2 inducing potential of RSV,
which is a point of conﬂict. Differences in data may be
attributed to strains of mice that are used in the procedure.
BALB/c mice tend to be more proﬁcient in producing Th2
responses than other strains such as C57BL. There does
seem to be agreement, for the most part, that RSV
enhances allergic disease. Some differences in studies
may be attributed to different mouse strains, but this does
not explain situations where Th1 responses are observed
to RSV in BALB/c mice. The question lies in how such a
response instigates allergy. In response, some studies have
suggested that RSV G protein speciﬁc CD4þT cells are
strong producers of IL-3, IL-4 and IL-5; whereas, F and M
protein speciﬁc T cells are more noted for IL-2 secretion
(Alwan and Openshaw, 1993; Alwan et al., 1994;
Bembridge et al., 1998). The majority of Th2 responses
are directed to a secreted form of the G protein, which may
be an evasive mechanism employed by RSV (Johnson
et al., 1998). F and M proteins are more immunogenic and
may mask G protein speciﬁc responses when looking at
RSV responses in vitro or in vivo. Nevertheless, G protein
induced Th2 responses may be sufﬁcient to evoke allergic
responses in the host animal.
In marked contrast to those who believe RSV infection
enhances allergic sensitization, some investigators have
suggested that RSV infections very early in life are
necessary for avoidance of atopic sensitization. Based on
murine and human studies they have suggested that RSV
instigates a strong Th1/IFNg response and imply that its
persistence during an early infection inﬂuences immune
responses to allergens (Juntti et al., 2003). Schwarze et al.
demonstrated that BALB/c mice only infected with RSV
displayed elevated IFNg and decreased IL-4 and IL-5 on
day 6 post infection in peribronchial lymph node
mononuclear cells stimulated with either phorbol 12,13
dibutyrat/ionomycin or RSV (Schwarze et al., 1997).
High amounts of IFNg and low IL-4 and IL-10 were also
observed in RSV restimulated PBMCs in a human study of
one hundred and eleven children under 6 months of age.
This study compares the results of severe RSV vs. mild
RSV infections and suggests other studies are
biased because severe cases are compared with healthy
non-infected children. Using this methodology, there
was no statistical correlation between Th2 cytokines
and disease severity (Brandenburg et al., 2000).
Other paramyxoviruses, such as measles virus have been
scrutinized for their ability to decrease the prevalence of
atopic disease and asthma. Industrialized countries where
vaccines, antibiotics and anti-viral drugs are commonly
used to prevent or treat infections reportedly are plagued
by high incidences of asthma and atopy (Message and
Johnston, 2002). In addition, rhinovirus infections, which
are most prevalent in infants under 6 months old, have
been suggested, along with RSV, to promote early Th1
responses (van Benten et al., 2003).
CONCLUSION
The inﬂuence of RSV infection on allergic sensitization
and the inﬂuence of allergic sensitization on RSV
bronchiolitis have been examined using relevant studies.
While the effects of LPS and allergen exposure on
pathogenesis of RSV infection have been well studied in
mouse models, the cellular and molecular events that
determine the ultimate outcome of the immune response
remain to be fully elucidated. Indeed, mechanisms that
favor the role of RSV in enhancing allergic sensitization
are very likely not the same as those that facilitate asthma
exacerbation when the allergic asthmatic child is infected
with RSV. Further studies in other appropriate model
systems such as the rhesus monkey/RSV and bovine
calf/BRSV species may help to elucidate the complex
interaction between virus, host and allergen.
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